Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years (2022)
D'Angelo, Natália A 
; Noronha, Mariana Akemi ; Câmara, Mayra C. C; Kurnik, Isabelle S ; Feng, Chuying; Araújo, Victor Hugo Sousa; Santos, João Henrique Picado Madalena ; Feitosa, Valker Araujo ; Molino, João Vitor Dutra ; Rangel-Yagui, Carlota de Oliveira ; Chorilli, Marlus ; Ho, Emmanuel A ; Lopes, André Moreni
Source: Materials Science & Engineering C. Unidade: FCF
Subjects: QUIMIOTERAPIA, ANTINEOPLÁSICOS, NEOPLASIAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
D'ANGELO, Natália A et al. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years. Materials Science & Engineering C, v. 133, p. 1-23 art. 112623, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2021.112623. Acesso em: 17 nov. 2024.APA
D'Angelo, N. A., Noronha, M. A., Câmara, M. C. C., Kurnik, I. S., Feng, C., Araújo, V. H. S., et al. (2022). Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years. Materials Science & Engineering C, 133, 1-23 art. 112623. doi:10.1016/j.msec.2021.112623NLM
D'Angelo NA, Noronha MA, Câmara MCC, Kurnik IS, Feng C, Araújo VHS, Santos JHPM, Feitosa VA, Molino JVD, Rangel-Yagui C de O, Chorilli M, Ho EA, Lopes AM. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years [Internet]. Materials Science & Engineering C. 2022 ; 133 1-23 art. 112623.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.msec.2021.112623Vancouver
D'Angelo NA, Noronha MA, Câmara MCC, Kurnik IS, Feng C, Araújo VHS, Santos JHPM, Feitosa VA, Molino JVD, Rangel-Yagui C de O, Chorilli M, Ho EA, Lopes AM. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years [Internet]. Materials Science & Engineering C. 2022 ; 133 1-23 art. 112623.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.msec.2021.112623
